Pharmacokinetics and Metabolism of the Plant Cannabinoids, Δ 9-Tetrahydrocannibinol, Cannabidiol and Cannabinol
- 1 January 2005
- book chapter
- review article
- Published by Springer Science and Business Media LLC
- No. 168,p. 657-690
- https://doi.org/10.1007/3-540-26573-2_23
Abstract
Increasing interest in the biology, chemistry, pharmacology, and toxicology of cannabinoids and in the development of cannabinoid medications necessitates an understanding of cannabinoid pharmacokinetics and disposition into biological fluids and tissues. A drug’s pharmacokinetics determines the onset, magnitude, and duration of its pharmacodynamic effects. This review of cannabinoid pharmacokinetics encompasses absorption following diverse routes of administration and from different drug formulations, distribution of analytes throughout the body, metabolism by different tissues and organs, elimination from the body in the feces, urine, sweat, oral fluid, and hair, and how these processes change over time. Cannabinoid pharmacokinetic research has been especially challenging due to low analyte concentrations, rapid and extensive metabolism, and physicochemical characteristics that hinder the separation of drugs of interest from biological matrices—and from each other—and lower drug recovery due to adsorption of compounds of interest to multiple surfaces. Δ 9-Tetrahydrocannabinol, the primary psychoactive component of Cannabis sativa, and its metabolites 11-hydroxy-Δ 9-tetrahydrocannabinol and 11-nor-9-carboxy-tetrahydrocannabinol are the focus of this chapter, although cannabidiol and cannabinol, two other cannabinoids with an interesting array of activities, will also be reviewed. Additional material will be presented on the interpretation of cannabinoid concentrations in human biological tissues and fluids following controlled drug administration.Keywords
This publication has 100 references indexed in Scilit:
- Metabolism of Δ9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeysLife Sciences, 1995
- Extrahepatic Metabolism of Drugs in HumansClinical Pharmacokinetics, 1994
- Brain microsomal oxidation of Δ8- and Δ9-tetrahydrocannabinolBiochemical and Biophysical Research Communications, 1988
- Drugs in Human MilkClinical Pharmacokinetics, 1988
- Presence of Δ9-Tetrahydrocannabinol in Human MilkNew England Journal of Medicine, 1982
- The Clinical Pharmacology and Dynamics of Marihuana Cigarette SmokingThe Journal of Clinical Pharmacology, 1981
- The Metabolism of Δ9‐Tetrahydrocannabinol and Related Cannabinoids in ManThe Journal of Clinical Pharmacology, 1981
- Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in manJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Separate radioimmune measurements of body fluid Δ9-THC and 11-nor-9-carboxy-Δ9-THCLife Sciences, 1976
- Binding of (+)- and (-)-Δ1-tetrahydrocannabinols and (-)-7-hydroxy-Δ1-tetrahydrocannabinol to blood cells and plasma proteins in manJournal of Pharmacy and Pharmacology, 1974